GI Dynamics signs up Medtronic and GSK for EndoBarrier research
This article was originally published in Clinica
Executive Summary
GI Dynamics, developer of the EndoBarrier obesity treatment device, has signed separate research deals with medtech and pharma giants Medtronic and GlaxoSmithKline.